-
Mashup Score: 1Resumption Of Medicaid Eligibility Redeterminations: Little Change In Overall Insurance Coverage - 21 hour(s) ago
In anticipation of the end of the COVID-19 public health emergency, Congress ended the Medicaid continuous coverage requirement on March 31, 2023, allowing states to terminate coverage for ineligible people and resume eligibility determinations through a process known as unwinding. Although administrative data have documented substantial declines in Medicaid enrollment since April 2023, the impact on uninsurance is unknown. Using data from the Census Bureau’s Household Pulse Survey, we estimated the early effect of Medicaid unwinding on insurance coverage among people ages 19–64. We found that within the first three months of unwinding, the number of people self-reporting Medicaid coverage declined by approximately two million, and there was a much smaller, statistically insignificant decline in overall coverage of approximately 467,000 people. It appears that for many people, the availability of employer-sponsored insurance and other private coverage offset Medicaid coverage loss. The
Source: www.healthaffairs.orgCategories: General Medicine News, PayerTweet
-
Mashup Score: 0Providers Paid Substantially Less By Marketplace Nongroup Insurers Than By Employer Small-Group Plans, 2021 - 2 day(s) ago
Numerous studies show that employer plans pay providers significantly more than Medicare, but less is known about prices in nongroup plans sold both on and off the Marketplaces established by the Affordable Care Act (ACA), where narrow networks and low-cost insurers are more prevalent. We estimated prices for three market segments (Marketplace nongroup, off-Marketplace nongroup, and employer small group) and three types of services (professional, outpatient hospital, and inpatient hospital) relative to a Medicare benchmark. We used 2021 claims data covering virtually all enrollment in ACA risk-adjusted plans. In aggregate, in 2021, Marketplace prices were 152 percent of Medicare prices, whereas the prices paid in small-group employer plans were 179 percent of Medicare prices. Comparing across market segments, relative to employer small-group plans, Marketplace professional prices were 6.9 percent lower, inpatient prices were 13.3 percent lower, and outpatient prices were 26.3 percent l
Source: www.healthaffairs.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2To Improve Quality And Outcomes, Incentivize Clinicians To Engage Patients | Health Affairs Forefront - 3 day(s) ago
New data indicate that when payment models reward clinicians for supporting patients to take an active role in their care, quality improves.
Source: www.healthaffairs.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Medicare Advantage Plans With High Numbers Of Veterans: Enrollment, Utilization, And Potential Wasteful Spending - 3 day(s) ago
Medicare Advantage (MA) plans are increasingly enrolling veterans. Because MA plans receive full capitated payments regardless of whether or not veterans use Medicare services, the federal government can incur substantial duplicative, wasteful spending if veterans in MA plans predominantly seek care through the Veterans Health Administration (VHA) system. The recent growth of MA plans that disproportionately enroll veterans could further exacerbate such wasteful spending. Using national data, we found that veterans increasingly enrolled in MA between 2016 and 2022, including in a growing number of MA plans in which 20 percent or more of the enrollees were veterans. Notably, about one in five VHA enrollees in these high-veteran MA plans did not incur any Medicare services paid by MA within a given year—a rate 2.5 times that of VHA enrollees in other MA plans and 5.7 times that of the general MA population. Meanwhile, VHA enrollees in high-veteran MA plans were significantly more likely
Source: www.healthaffairs.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1
Biosimilars present a key opportunity to contain the growing cost of biologic drug spending and to make essential medications more affordable. However, the lackluster performance of the US biosimilar market in its first decade was met with disappointment and concern for its future viability. To evaluate the evolution of the biosimilar market, we reviewed key distinctions in medication classes and the financial stakeholders involved in each. Within this context, we examined recent evidence that suggests that the maturing postapproval biosimilar marketplace is flourishing. The entry of biosimilars for adalimumab offers a case study demonstrating these recent market and policy dynamics. Building on recent gains, policy makers could take additional steps to accelerate biosimilar adoption through both payment and regulatory policy levers.
Source: www.healthaffairs.orgCategories: General Medicine News, PayerTweet-
As biosimilars evolve as an affordable option for essential medicine, Janice Jhang of @Harvard and Troyen A. Brennan explore key differences in medication classes and financial stakeholders that could be driving drug adoption. Read the full article here: https://t.co/zZ2t3fLD23 https://t.co/bZXbCIJek0
-
-
Mashup Score: 1Science And The US Supreme Court | Health Affairs Forefront - 5 day(s) ago
The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or scientific issues that come before it. The judiciary must develop subject matter knowledge, if not expertise, in increasingly more complex and sophisticated disciplines only remotely related to traditional jurisprudential disciplines.
Source: www.healthaffairs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Quantifying upstream drivers of health can help compound improvement in downstream outcomes - 5 day(s) ago
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? Nivedha Subburaman, MDS; Pavan Kumar Bhoslay; Maningbè Keita Fakeye, PhD; Jay Bhatt, DO, MPH MPA; Elya Papoyan, MPH | November 13, 2024 Publisher’s note: This material was paid for by Deloitte and provided by Deloitte. The views expressed by the author are their own. This material is not part of Health Affairs Forefront;
Source: www.healthaffairs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5The Impact Of The Election On Health Policy And The Courts | Health Affairs Forefront - 6 day(s) ago
The recent election results will usher in sweeping changes for major federal health care policies, programs, and the courts.
Source: www.healthaffairs.orgCategories: General Medicine News, PayerTweet
-
Mashup Score: 0Health Benefits In 2024: Higher Premiums Persist, Employer Strategies For GLP-1 Coverage And Family-Building Benefits - 7 day(s) ago
In 2024, the average annual premium for employer-sponsored family health coverage was $25,572, an increase of $1,604 (7 percent) from 2023. Over the course of the past five years, the average family premium has increased 24 percent, which is similar to growth seen in inflation (23 percent) and wages (28 percent). On average, covered workers contributed 16 percent ($1,368) of the cost of single coverage and 25 percent ($6,296) of the cost of family coverage. The average general annual deductible for single coverage for workers with a deductible was $1,787, similar to that in recent years but 47 percent higher than a decade ago. In 2024, 18 percent of large firms offering health benefits, including 28 percent of those with 5,000 or more employees, covered GLP-1 antagonists for weight loss. Large employers were more likely to perceive their overall provider networks as broader than their networks for mental health and substance use conditions.
Source: www.healthaffairs.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Podcast: Dion's Chicago Dream Fights Food Insecurity One Meal At A Time | Health Affairs Podcast - 8 day(s) ago
In the first episode of the second season of Research and Justice For All, host Rhea Boyd, MD, MPH, Pediatrician and Child and Public Health Advocate, interviews Dion Dawson from Dion’s Chicago Dream about innovative ways to address food insecurity. They also explore the nonprofit industrial complex and the systemic link between hunger and profit in the US.
Source: www.healthaffairs.orgCategories: General Medicine News, PediatricsTweet
Sumedha Gupta of @IndianaUniv and coauthors examine the impact of the termination of ineligible Medicaid plans in 2023 on rates of unwinding and overall insurance coverage. Read the full article here: https://t.co/bvwR9YlT1u